Please login to the form below

Not currently logged in
Email:
Password:

off label

This page shows the latest off label news and features for those working in and with pharma, biotech and healthcare.

UPDATED: J&J's $8bn Risperdal judgment reduced to $6.8m

UPDATED: J&J's $8bn Risperdal judgment reduced to $6.8m

Risperdal isn’t approved for that use, but was prescribed off-label – something that is legal based on physician judgment. ... off-label use in children.

Latest news

More from news
Approximately 3 fully matching, plus 173 partially matching documents found.

Latest Intelligence

  • Rare disease trials Q&A Rare disease trials Q&A

    For studies using repurposed drugs, participation can be compromised by off- label usage outside a controlled research setting.

  • Five questions guiding the way to actual patient-centricity Five questions guiding the way to actual patient-centricity

    We worry about the effort real patients might make, the risks of social media, pharmacovigilance, off-label questions and a minefield of legal requirements.

  • Significant figures Significant figures

    Fast forward to last September and the company’s decision to put ALIS through phase III trials paid off, when it released late-stage results showing 29% of patients with NTM ... or less off-label as it’s not specifically indicated to treat the

  • Healthcare systems

  • The gold standard of scientific evidence The gold standard of scientific evidence

    More than one in five prescriptions in the United States are for an off-label use; providing additional evidence to better understand treatment efficacy and safety is crucial.

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...

Infographics